Results 201 to 210 of about 4,414 (225)

Impact of left atrial appendage closure on left atrial function: insights from the OCEAN-LAAC registry

European Heart Journal
Abstract Background Percutaneous left atrium appendage closure (LAAC) is an effective therapy to prevent thromboembolic events among patients with atrial fibrillation (AF) (Ref 1). However, since the left atrium appendage (LAA) potentially serves as a part of the left atrium (LA) volume and a buffer ...
Hideaki Nonaka, Masahiko Asami, Yu Horiuchi, Jun Tanaka, Daiki Yoshiura, Kota Komiyama, Hitomi Yuzawa, Kengo Tanabe   +7 more
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Left atrial appendage closure (LAAC) in cancer patients: A systematic review and meta-analysis.

Journal of Clinical Oncology
e24010 Background: Cancer increases the risk of atrial fibrillation (AF), particularly in patients over 65 or those with pre-existing cardiovascular disease. Patients with active cancer are at a higher risk of arterial and venous thrombosis.
Anirudra Devkota, Abhigan Babu Shrestha, Anil KC, Shueb Mohamed, Vikash Jaiswal, Sajina Shrestha, Dipesh Rohita   +6 more
openaire   +1 more source

Incentivos e benefícios fiscais nas IPSS: caso de estudo LAAC

2017
Currently, public aid is extremely selective and is not capable of responding to all of the requests from social institutions. Over the last few years, state subsidies to the Non-profit Sector (NPS) have decreased considerably, putting into jeopardy the sustainability of this sector, which has important objectives in social protection.
openaire   +1 more source

Applying 3Rs Principles for Large-Animal Research: A Case Example From Preclinical LAAC Study

Cardiovascular Revascularization Medicine, 2022
Dongming Hou, Ed Kopesky, Matthew Palin, Jason Kilvington, Dominic Allocco, Sean Lilienfeld, Ian Meredith   +6 more
openaire   +1 more source

Impact of Device Compression on Peridevice Leak After Left Atrial Appendage Closure: The Impression LAAC Study.

Background Left atrial appendage closure (LAAC) is an established therapeutic strategy to prevent ischemic stroke in selected patients with atrial fibrillation. However, residual peridevice leaks (PDLs) post-LAAC remain a critical concern.Objectives This study sought to assess the clinical impact of Watchman FLX device overcompression.Methods Data on ...
La Fazia, Vincenzo Mirco, Galea, Roberto, Della Rocca, Domenico Giovanni, Gianni, Carola, Gasys, Antanas, Mohanty, Sanghamitra, Madhkour, Raouf, Pierucci, Nicola, Torlapati, Prem Geeta, Chalkou, Konstantina, Chiricolo, Gaetano, Chong-Nguyen, Caroline Tuyet Vi, Horton, Rodney, Al-Ahmad, Amin, Di Biase, Luigi, Räber, Lorenz, Natale, Andrea   +16 more
openaire   +1 more source

CRT-700.45 Applying 3Rs Principles for Large-Animal Research: A Case Example From Preclinical LAAC Study

JACC: Cardiovascular Interventions, 2022
Dongming Hou, Ed Kopesky, Matthew Palin, Jason Kilvington, Dominic Allocco, Sean Lilienfeld, Ian Meredith, null Marlborough   +7 more
openaire   +1 more source

LAAC trumps warfarin in AF stroke prevention

PharmacoEconomics & Outcomes News, 2014
openaire   +1 more source

Preclinical Evaluation of Long Acting Anticholinergics (LAAC): Comparison of Tiotropium and Investigational Drugs.

C49. COPD: PHARMACOLOGICAL TREATMENT LAMA, 2009
P Casarosa, T Bouyssou, F Gantner, MP Pieper   +3 more
openaire   +1 more source

LAAC with Watchman device offers cost savings in NVAF

PharmacoEconomics & Outcomes News, 2016
openaire   +1 more source

LAAC

2010
openaire   +1 more source